Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented…
The right AI model applied to the right problem exponentially enhances our ability to match patients with potentially life saving treatments faster and more effectively. The only “trick” required for truly successful AI integration — in life sciences or any other facet of the healthcare industry — is clarity of purpose. The post First Principles…
SDOH screenings are a critical tool, but they are only the first step. By measuring without offering solutions, we’re perpetuating reactivity and creating a system of injustice. The post Beyond Screening: Addressing Social Challenges After the Questions Are Asked appeared first on MedCity News.
Through a new partnership, Priority Health members will be able to receive virtual gastrointestinal care from Ayble Health. The post Priority Health Taps Ayble Health to Address GI Disorders appeared first on MedCity News.
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California. The post FDA Approves First At-Home Cervical Cancer Test appeared first on MedCity News.
We may be on the eve of the next breakthrough: a new combination of “old” algorithms that promises to radically accelerate the discovery and development of new medicines. The post AI’s Next Act: New Medicines appeared first on MedCity News.
[Sponsored] Discover nine top caregiver services with flexible scheduling to fit changing routines, shift work or evolving health needs — featuring trusted platforms and in-home care providers. The post 9 Ways to Find Caregivers With Flexible Scheduling Options appeared first on MedCity News.
Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it’s about better science, improved patient outcomes, and equitable healthcare access. The post Patient-Centricity is Reliant on Representative Clinical Studies appeared first on MedCity News.
Verastem Oncology developed its drug combination for low-grade serous ovarian cancer (LGSOC) driven by KRAS mutations. As the first treatment specifically approved for this rare cancer, clinicians expect it will become the new standard of care. The post Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer appeared first…
Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor. The post Withings, Babyscripts Team Up to Tackle Hypertensive Disorders of Pregnancy appeared first on MedCity News.